Evidence map›Paper›PMID 34998398›Full record

ReviewEnvironmental health : a global access science source2022

Towards a paradigm shift in environmental health decision-making: a case study of oxybenzone.

Klara Matouskova, Laura N Vandenberg

Abstract readReview
In one paragraph

Review in Environmental health : a global access science source, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Toxics · 2023
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Klara MatouskovaDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts - Amherst, 171C Goessmann, 686 N. Pleasant Street, Amherst, MA, 01003, USA.
Laura N VandenbergDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts - Amherst, 171C Goessmann, 686 N. Pleasant Street, Amherst, MA, 01003, USA. lvandenberg@schoolph.umass.edu.ORCID 0000-0002-6807-9136

Funding

Metabolomics Administrative Supplement: Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures during pregnancyU01ES026140 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI JERRY, D. JOSEPH, SCHNEIDER, SALLIE SMITH · 2015 to 2019
$3.7M
NIEHS NIH HHS U01ES026140
6 · The paper itself

Abstract

backgroundTechnological advancements make lives safer and more convenient. Unfortunately, many of these advances come with costs to susceptible individuals and public health, the environment, and other species and ecosystems. Synthetic chemicals in consumer products represent a quintessential example of the complexity of both the benefits and burdens of modern living. How we navigate this complexity is a matter of a society's values and corresponding principles.

objectivesWe aimed to develop a series of ethical principles to guide decision-making within the landscape of environmental health, and then apply these principles to a specific environmental chemical, oxybenzone. Oxybenzone is a widely used ultraviolet (UV) filter added to personal care products and other consumer goods to prevent UV damage, but potentially poses harm to humans, wildlife, and ecosystems. It provides an excellent example of a chemical that is widely used for the alleged purpose of protecting human health and product safety, but with costs to human health and the environment that are often ignored by stakeholders. DISCUSSION: We propose six ethical principles to guide environmental health decision-making: principles of sustainability, beneficence, non-maleficence, justice, community, and precautionary substitution. We apply these principles to the case of oxybenzone to demonstrate the complex but imperative decision-making required if we are to address the limits of the biosphere's regenerative rates. We conclude that both ethical and practical considerations should be included in decisions about the commercial, pervasive application of synthetic compounds and that the current flawed practice of cost-benefit analysis be recognized for what it is: a technocratic approach to support corporate interests.

Indexed as

BenzophenonesEcosystemEnvironmental HealthHumansSocial JusticeBenzophenonesoxybenzoneBenzophenone 3Conflicting interestsEndocrine disruptorExternalityIntergenerationalMelanomaSkin cancerSunscreen

Identifiers

PMID34998398
PMCPMC8742442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.